← Leaderboards
Dawn A Fishbein
Mount Sinai School Of Medicine Of Nyu
$1,482,561
Attributed
$1,482,561
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $250K · FY2005–13$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$999,055 · 3
CDC$483,506 · 1
By mechanism
K23$874,593 · 1
U51$483,506 · 1
M01$124,462 · 2
Top collaborators
No co-investigators on record.
Most similar at Mount Sinai School Of Medicine Of Nyu
Same institution · by research overlap
- Scott Laurence Friedman$20,818,456
- Natalia Nieto$11,228,892
- Edward A Fisher$34,926,928
- Andrea D. Branch$14,715,515
- Savio L Woo$12,415,247
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionResearch PersonnelVaccinationHepatitis C VirusClinical ResearchCommunicable DiseasesHiv InfectionsHepatitis AHepatitis CAlcohol AbuseAntiviral AgentsAntibodiesAppointmentAttentionAddictionChemotherapyAlcoholsBloodBehavioral /Social Science Research TagAlcoholism /Alcohol AbuseCareerCaringCause Of DeathAffect
Grant awards (9)
EARLY IDENTIFICATION AND LINKAGE TO CARE FOR PERSONS WITH CHR$233,506
U51 · FY2013 · PS · contact PI
EARLY IDENTIFICATION AND LINKAGE TO CARE FOR PERSONS WITH CHR$250,000
U51 · FY2012 · PS · contact PI
PROTECTIVE IMMUNITY TO HBV IN HIV+ PATIENTS WITH ISOLATED HEPATITIS B$53,822
M01 · FY2009 · RR · contact PI
Pre-Chemotherapeutic Care of HCV Infected Drug Users$175,986
K23 · FY2008 · DA · contact PI
PROTECTIVE IMMUNITY TO HBV IN HIV+ PATIENTS WITH ISOLATED HBV CORE ANTIBODY$70,640
M01 · FY2008 · RR · contact PI
Pre-Chemotherapeutic Care of HCV Infected Drug Users$175,986
K23 · FY2007 · DA · contact PI
Pre-Chemotherapeutic Care of HCV Infected Drug Users$175,826
K23 · FY2006 · DA · contact PI
Pre-Chemotherapeutic Care of HCV Infected Drug Users$174,211
K23 · FY2005 · DA
Pre-Chemotherapeutic Care of HCV Infected Drug Users$172,584
K23 · FY2004 · DA